Neuroscience

ADHD and the Dopamine Story: What I'm Reading Right Now

July 12, 2026 · by Brendon Kennedy

I don’t write these to explain ADHD to anyone. I write them to force myself to actually read the papers instead of absorbing pop-neuroscience by osmosis. This is my current snapshot of what the research says about ADHD as a difference in dopamine signaling and executive function — and, just as important, where that story is messier than the headlines.

The tidy “low dopamine” story is too tidy

The version you hear everywhere is: ADHD is a dopamine deficit, stimulants add dopamine, done. The literature I’ve been reading doesn’t support anything that clean.

Start with the dopamine transporter (DAT) — the protein that clears dopamine back out of the synapse, and the direct target of methylphenidate. A widely cited meta-analysis by Fusar-Poli and colleagues pooled nine imaging studies (169 people with ADHD, 173 controls) and found striatal DAT density about 14% higher on average in ADHD. Sounds like a clean biomarker — until the next finding: the effect flipped with medication history. DAT density was higher in previously medicated patients and lower in medication-naive ones. The authors’ read is that elevated DAT may be partly an adaptation to stimulant exposure rather than a pure baseline feature of ADHD.

That’s the kind of nuance that changes how I hold the whole topic: a lot of “ADHD brain” imaging is confounded by the very treatment being studied. Association, not a personal readout.

Where the signal is more consistent: reward anticipation

The finding that holds up better isn’t a molecule count — it’s timing. When you anticipate a reward, the ventral striatum normally ramps up. A meta-analysis of fMRI studies by Plichta and Scheres found that in ADHD this anticipatory ramp is blunted — ventral-striatal hyporesponsiveness during reward anticipation, a medium effect size (Cohen’s d ≈ 0.48–0.58).

I find this more useful than “low dopamine” because it’s about reward prediction, not reward itself. The dopamine system is largely a prediction-and-timing system; it fires to signal that something better-than-expected is coming. If that anticipatory signal is weak or noisy, distant rewards (finish the report) lose out to immediate ones (check the phone) — not because of a willpower gap but because the forecasting circuit is quieter. That maps onto delay-discounting far better than any deficit-of-effort story. It’s still a group-level pattern, not a switch you’d read off one person’s scan.

The prefrontal cortex and the inverted U

Executive function — holding a goal in mind, filtering noise, inhibiting the wrong response — leans heavily on the prefrontal cortex (PFC), and the PFC is exquisitely sensitive to catecholamine levels. Arnsten and Pliszka describe an inverted-U: too little dopamine and norepinephrine and PFC networks can’t sustain firing; too much and neurons disconnect and performance collapses again. Optimal function sits in a narrow middle, tuned by α2A- and D1-receptor stimulation.

This is the detail that finally made stimulant dosing make sense to me. The goal isn’t “more dopamine.” It’s landing near the top of the curve — which is why a dose that helps can tip into wired, brittle, and worse if it’s too high. Same molecule, opposite effect, depending on where you already sit on the U.

The default-mode network: not just “not enough focus”

The newer thread I’ve been following is network-level. Your brain has a default-mode network (DMN) that’s active during mind-wandering and self-referential thought, and it’s normally anticorrelated with the task-positive networks you use to focus — one goes up, the other goes down. The default-mode interference hypothesis says that in ADHD this anticorrelation is weaker, so DMN activity intrudes during tasks and produces the lapses and reaction-time variability that are so characteristic.

What moved this from hypothesis to something I take seriously is a large “big data” mega-analysis by Norman and colleagues — roughly 2,600 people in a case-control comparison plus a 10,000-plus trait sample — that found exactly this: less anticorrelation between the default-mode network and the salience, dorsal-attention, and somatomotor networks in ADHD. The caveat the authors state plainly: the effect sizes were small. A real group-level difference, not a diagnostic test.

Where the field is actually heading

The synthesis I keep landing on comes from two 2024 reviews. The Nature Reviews Disease Primers ADHD overview still puts dopamine and norepinephrine at the center of both pathophysiology and why medications work. But a 2024 Nature Reviews Neuroscience piece argues the field is moving away from a single localized “dopamine-deficit-in-region-X” model toward a brain-wide, heterogeneous picture — many partial contributors, large individual variation, no one lesion.

So my honest one-liner: ADHD looks less like a broken dopamine gauge and more like a regulation and timing difference — in reward prediction, in prefrontal tuning, and in how networks hand off attention — spread across a lot of people who don’t all share the same biology.

What I’m actually doing

None of this is a protocol. It’s a lens for tweaking habits and noticing what changes:

• Front-loading the reward signal. If the anticipation circuit is quiet, I try to make the near-term payoff louder — a short, bounded work block with a clear finish line, and something concrete that marks a task as done so there’s an actual “that happened” signal instead of an open-ended slog.
• Respecting the inverted U with stimulation, not just meds. Over-caffeinating past my sweet spot reliably makes me worse, not better — jittery and scattered rather than sharp — so I treat stimulation as something to keep inside a band rather than to maximize, and I back off the moment focus tips over into wired.
• Using movement as a reset. I keep up a regular easy-running habit; whether that genuinely changes my task-switching or just clears my head for an afternoon, I honestly can’t separate — so I’m holding it as an open question rather than claiming exercise fixed my focus.
• Shrinking the DMN’s opening. Single-tabbing and getting the phone out of the room isn’t willpower theater for me — it’s cutting the cues that let mind-wandering win the handoff.

I’ll update this as I read more. If a claim here later turns out to rest on a shaky study, I’d rather cut it than keep a clean story.

Not medical advice. This is a personal catalog of research I’m reading and habits I’m testing on myself. Nothing here diagnoses, treats, or prevents any disease, and it isn’t a substitute for a qualified clinician. Talk to your doctor before changing diet, fasting, exercise, or medication — especially with ADHD medication, alcohol, or a personal or family cancer history.

← All writing